AU6777596A - Treatment of human prostate disease with beta-lapachone derivatives - Google Patents

Treatment of human prostate disease with beta-lapachone derivatives

Info

Publication number
AU6777596A
AU6777596A AU67775/96A AU6777596A AU6777596A AU 6777596 A AU6777596 A AU 6777596A AU 67775/96 A AU67775/96 A AU 67775/96A AU 6777596 A AU6777596 A AU 6777596A AU 6777596 A AU6777596 A AU 6777596A
Authority
AU
Australia
Prior art keywords
beta
treatment
human prostate
prostate disease
lapachone derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67775/96A
Inventor
Chiang J. Li
Arthur Pardee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Publication of AU6777596A publication Critical patent/AU6777596A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU67775/96A 1995-08-25 1996-08-19 Treatment of human prostate disease with beta-lapachone derivatives Abandoned AU6777596A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US282995P 1995-08-25 1995-08-25
US002829 1995-08-25
PCT/US1996/013335 WO1997007797A1 (en) 1995-08-25 1996-08-19 Treatment of human prostate disease with beta-lapachone derivatives

Publications (1)

Publication Number Publication Date
AU6777596A true AU6777596A (en) 1997-03-19

Family

ID=21702722

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67775/96A Abandoned AU6777596A (en) 1995-08-25 1996-08-19 Treatment of human prostate disease with beta-lapachone derivatives

Country Status (2)

Country Link
AU (1) AU6777596A (en)
WO (1) WO1997007797A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245807B1 (en) * 1995-08-24 2001-06-12 Dana-Farber Cancer Institute Treatment of human prostate disease
US6962944B2 (en) * 2001-07-31 2005-11-08 Arqule, Inc. Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same
WO2003090710A1 (en) * 2002-04-23 2003-11-06 Case Western Reserve University Lapachone delivery systems, compositions and uses related thereto
US20140161720A1 (en) * 2011-05-26 2014-06-12 The General Hospital Corporation Treatment of angiogenic- or vascular-associated diseases
KR102647100B1 (en) 2015-05-30 2024-03-13 몰레큘러 템플레이츠, 인코퍼레이션. Deimmunized Shiga toxin A subunit scaffolds and cell-targeting molecules comprising the same
CN105503692B (en) * 2015-12-27 2017-12-26 新乡医学院 A kind of α lapachols analog and its synthetic method and the application as antineoplastic
CN106074492A (en) * 2016-06-13 2016-11-09 中山大学 9-methoxyl group-α-lapachol is as the purposes of indole amine 2,3-dioxygenase-1 inhibitor

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004145A1 (en) * 1992-08-21 1994-03-03 Dana Farber Cancer Institute Treatment of human viral infections

Also Published As

Publication number Publication date
WO1997007797A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
AU7578696A (en) Morpholine derivatives and their use as therapeutic agents
AU4473596A (en) Methods of human prostate cancer diagnosis
AU703189B2 (en) Modification of pacemaker tachy response based on FFRW sensing
AU5772196A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU5788396A (en) Methods of inhibition or killing of cancer cells
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
AU2039800A (en) 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU5772296A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU7012496A (en) Compounds and methods for treatment and diagnosis of prostate cancer
AU5772396A (en) 3,4-disubstituted-phenylsulphonamides and their therapeutic use
AU1773600A (en) Topical treatment of skin disease
AU5135296A (en) Use of protealytic enzymes in the treatment of insect bites
AU1350797A (en) Artificial skin construction
AU6104896A (en) Therapeutic microdevices and methods of making and using sam e
AU7166896A (en) Cancer treatment
AU6777596A (en) Treatment of human prostate disease with beta-lapachone derivatives
AU2265695A (en) The use of sertraline to treat cancer patients
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU7139996A (en) Mercaptoamide derivatives and their therapeutic use
AU6829696A (en) Treatment of solutions
AU8185491A (en) Treatment of disease
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU7750794A (en) Use of hydroxychloroquine for treatment of graft-versus-host disease
AU5984196A (en) Treatment and prevention of prostatic disease